• Flash Briefings & Podcasts

  Study Suggests Antacid Therapy May Not Benefit IPF Patients or Impact Outcomes

  Posted by pulmonary-fibrosis-news-moderator on July 8, 2019 at 6:37 am

  

  Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses an Australian study that suggests that antacid therapy may not benefit IPF patients or impact outcomes.

  What are your thoughts about this study and its findings?

  pulmonary-fibrosis-news-moderator replied 4 years, 9 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply